Related Experiment Video
Updated: May 25, 2026
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Predictors of aggressive inflammatory bowel disease
Andres J Yarur1, Sebastian G Strobel, Amar R Deshpande
1Drs. Yarur and Strobel are Fellows and Dr. Deshpande is an Assistant Professor of Clinical Medicine in the Department of Medicine's Division of Gastroenterology at the University of Miami's Miller School of Medicine in Miami, Florida. Dr. Abreu serves as Chief of the Division of Gastroenterology, Professor of Medicine, and Professor of Microbiology and Immunology at the University of Miami's Miller School of Medicine in Miami, Florida.
Identifying aggressive inflammatory bowel disease (IBD) is crucial for treatment. This review highlights key demographic, clinical, and genetic markers that predict severe Crohn's disease and ulcerative colitis, aiding therapeutic decisions.
Area of Science:
- Gastroenterology
- Immunology
- Genetics
Background:
- Inflammatory bowel disease (IBD) encompasses idiopathic gastrointestinal inflammation with variable disease courses.
- Predicting disease severity is vital for effective therapeutic strategies.
Purpose of the Study:
- To review current evidence on markers predicting aggressive inflammatory bowel disease (IBD).
- To identify factors associated with severe Crohn's disease and ulcerative colitis.
Main Methods:
- Review of demographic, clinical, endoscopic, histologic, serologic, and genetic markers.
- Defined aggressive disease criteria for Crohn's disease and ulcerative colitis.
Main Results:
- Crohn's disease markers include upper GI/ileal involvement, penetrating disease, early onset, smoking, mucosal ulceration, high antibodies, and NOD2 mutations.
- Ulcerative colitis markers include pancolitis, plasmocytic infiltration, and crypt atrophy, predicting colectomy risk and treatment failure.
- No single method predicts aggressiveness; multiple markers improve accuracy.
Conclusions:
- Clinical manifestations are currently the most useful for therapeutic decisions in IBD.
- Ongoing development of serologic and genetic tests aims to refine prediction of IBD aggressiveness.
- Early identification of aggressive IBD subtypes is essential for personalized patient management.
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:26Inflammatory Bowel Disease I: Introduction
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...